#healthinnovation
New pancreatic cancer drug shows major survival gains in Phase 3 study
REDWOOD CITY, California — Revolution Medicines announced positive results from a late-stage clinical trial evaluating its experimental drug daraxonrasib, showing a significant survival benefit for patients with advanced pancreatic cancer who had previously undergone treatment. According to the company, patients receiving the once-daily oral therapy lived a median of 13.2 months, compar
New pancreatic cancer drug shows major survival gains in Phase 3 study
REDWOOD CITY, California — Revolution Medicines announced positive results from a late-stage clinical trial evaluating its experimental drug daraxonrasib, showing a significant survival benefit for patients with advanced pancreatic cancer who had previously undergone treatment. According to the company, patients receiving the once-daily oral therapy lived a median of 13.2 months, compar
AI market faces shakeout as Bill Gates warns of overvalued companies
The rapidly expanding artificial intelligence sector may face a significant reshuffling as Bill Gates warned that not all high-valued companies will survive in what he described as an increasingly “hyper competitive” market. Speaking at an event in Abu Dhabi, Gates said that although AI represents one of the most transformative technologies of the era, it does not guarantee universal success for companies riding the wave of investor enthusiasm. His remarks come at a time when global marke
AI market faces shakeout as Bill Gates warns of overvalued companies
The rapidly expanding artificial intelligence sector may face a significant reshuffling as Bill Gates warned that not all high-valued companies will survive in what he described as an increasingly “hyper competitive” market. Speaking at an event in Abu Dhabi, Gates said that although AI represents one of the most transformative technologies of the era, it does not guarantee universal success for companies riding the wave of investor enthusiasm. His remarks come at a time when global marke









